State Of Wisconsin Investment Board Biocryst Pharmaceuticals Inc Transaction History

State Of Wisconsin Investment Board

$37.8 Billion
Q3 2024

A detailed history of State Of Wisconsin Investment Board transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 183,928 shares of BCRX stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

183,928

Previous 233,547 21.25%

Holding current value

$1.4 Million

Previous $1.44 Million 3.19%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.41 - $8.69 $318,057 - $431,189	-49,619 Reduced 21.25%	183,928 $1.4 Million
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $399,362 - $656,579	96,698 Added 70.66%	233,547 $1.44 Million
Q1 2024 May 14, 2024	SELL	$4.89 - $7.65 $87,589 - $137,026	-17,912 Reduced 11.57%	136,849 $695,000
Q4 2023 Feb 12, 2024	SELL	$4.98 - $6.77 $220,394 - $299,613	-44,256 Reduced 22.24%	154,761 $927,000
Q3 2023 Nov 14, 2023	SELL	$6.71 - $7.92 $341,304 - $402,850	-50,865 Reduced 20.36%	199,017 $1.41 Million
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $72,397 - $91,641	10,402 Added 4.34%	249,882 $1.76 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $419,986 - $626,276	52,895 Added 28.35%	239,480 $2 Million
Q4 2022 Feb 14, 2023	SELL	$10.5 - $14.2 $24,328 - $32,901	-2,317 Reduced 1.23%	186,585 $2.14 Million
Q3 2022 Nov 14, 2022	SELL	$10.79 - $14.81 $75,508 - $103,640	-6,998 Reduced 3.57%	188,902 $2.38 Million
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $330,591 - $749,172	-41,900 Reduced 17.62%	195,900 $2.07 Million
Q1 2022 May 13, 2022	SELL	$11.56 - $19.76 $253,164 - $432,744	-21,900 Reduced 8.43%	237,800 $3.87 Million
Q2 2021 Aug 12, 2021	SELL	$9.5 - $17.24 $87,400 - $158,608	-9,200 Reduced 3.42%	259,700 $4.11 Million
Q1 2021 May 17, 2021	SELL	$7.37 - $13.61 $170,247 - $314,391	-23,100 Reduced 7.91%	268,900 $2.74 Million
Q4 2020 Feb 03, 2021	SELL	$3.37 - $8.61 $164,793 - $421,029	-48,900 Reduced 14.34%	292,000 $2.18 Million
Q3 2020 Nov 16, 2020	BUY	$3.43 - $5.53 $377,643 - $608,853	110,100 Added 47.7%	340,900 $1.17 Million
Q2 2020 Aug 12, 2020	BUY	$1.9 - $5.61 $4,180 - $12,342	2,200 Added 0.96%	230,800 $1.1 Million
Q1 2020 May 06, 2020	BUY	$1.6 - $4.11 $101,600 - $260,985	63,500 Added 38.46%	228,600 $457,000
Q3 2019 Nov 12, 2019	BUY	$2.5 - $3.73 $31,250 - $46,625	12,500 Added 8.19%	165,100 $473,000
Q2 2019 Aug 14, 2019	BUY	$2.91 - $9.15 $9,894 - $31,110	3,400 Added 2.28%	152,600 $578,000
Q1 2019 May 13, 2019	BUY	$7.38 - $9.72 $270,846 - $356,724	36,700 Added 32.62%	149,200 $1.21 Million
Q4 2018 Feb 11, 2019	BUY	$6.51 - $9.6 $79,422 - $117,120	12,200 Added 12.16%	112,500 $908,000
Q2 2018 Aug 03, 2018	BUY	$4.6 - $6.52 $203,779 - $288,836	44,300 Added 79.11%	100,300 $575,000
Q3 2017 Nov 01, 2017	BUY	$4.1 - $5.97 $229,599 - $334,320	56,000	56,000 $293,000

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account

State Of Wisconsin Investment Board Biocryst Pharmaceuticals Inc Transaction History